CoronaVac vaccine gives immune response

“CoronaVac”, a potential unactivated vaccine against Covid-19, developed by the Chinese biofarmacetic company “Sinovac Biotech”, has emerged to be safe and tolerant and may provide a quick immune response, taking into account the results of clinical studies of the first and medium stage published by the science magazine “The Lancet [...]
“CoronaVac”, a potential unactivated vaccine against Covid-19, developed by the Chinese biofarmacetic company “Sinovac Biotech”, has emerged to be safe and tolerant and may give a quick immune response, taking into account the results of the clinical studies of the first and medium stage published by the science magazine “The Lancet Infectius <ex> writes <6-884>>
The level of antibodies caused by the vaccine was lower than the one found in patients who were recovered from Avid-19, showing however that he was able to protect the human body from the coronary invertetion.











